We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8410:TSESeven Bank, Ltd. Analysis

Data as of 2026-03-15 - not real-time

¥268.60

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Seven Bank is trading just above its immediate support of ¥267.80 with a current price of ¥268.6, while the 20‑day SMA (¥288.52) sits well above the market, indicating short‑term pressure. The RSI of 30.35 places the stock in oversold territory, suggesting a potential rebound, but the MACD remains bearish (line below signal, negative histogram), tempering optimism. Volume is on an increasing trend, adding weight to any near‑term price movement. On the fundamentals side, the company boasts a strong cash position (¥984 bn) against modest debt (¥107 bn), a dividend yield of 4.1% with a 70% payout ratio, and a PE of 17.24 that is slightly above the industry average of 16.35, rendering the valuation essentially fair. Revenue growth of 5.1% and an operating margin of 12.4% point to modest but steady earnings, while the low beta of 0.30 signals limited market‑wide volatility exposure. However, a 30‑day volatility of 25% and a max drawdown of 20% highlight notable price swings, especially as the stock sits near its support level.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI in oversold region indicating possible bounce
  • Price hovering just above key support level
  • High dividend yield providing immediate income

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable cash‑to‑debt profile supporting dividend continuity
  • Modest revenue growth and solid operating margins
  • Valuation near fair value with limited upside to resistance

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong balance sheet with ample liquidity
  • Consistently attractive dividend yield and payout ratio
  • Low beta and defensive positioning within the regional banking sector

Key Metrics & Analysis

Financial Health

Revenue Growth5.10%
Profit Margin5.68%
P/E Ratio17.2
ROE4.31%
ROA0.67%
P/B Ratio1.1
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI30.4
Support¥267.80
Resistance¥302.70
MA 20¥288.52
MA 50¥296.52
MA 200¥284.54
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price¥300.00
Upside/Downside11.69%
GradeFair
TypeBlend
Dividend Yield4.10%

Risk Assessment

Beta0.30
Volatility25.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.